compounded semaglutide ending Hims & Hers stock falls 25% as FDA curtails GLP-1s Compound versions of GLP-1 drugs

Compliance and Risk: With GLP-1s, compliance isnt just box-checking

Chris Serres: The women I interviewed said that it didnt completely eliminate their cravings, but it sort of quieted their brain enough that they could look at, why they say wanted to drink or why they wanted to, take, cocaine or, or heroin in a very rational way and be able to think it through

Note on humans: These benefits are not established in humans injectable NAD+ is not FDA-approved and lacks adequate controlled efficacy trials [13]

These are not direct pharmacological effects of the medication

Be sure to document your symptoms and share them with your doctor

"Or it could be happening when they've completed the course of treatment and they're in that maintenance and relapse prevention phase, which can [also] be a high-risk phase." According to the Butterfly Foundation, more than 1.1 million people across Australia have an eating disorder